Moreover, reduced expression of PRC1 suppresses the proliferation and invasion of lung adenocarcinoma cells in vitro and in vivo by inducing G2/M phase cell cycle arrest and apoptosis, suggesting that PRC1 may serve as an oncogene and potential therapeutic biomarker for lung adenocarcinoma. The gene discussed is PRC1; the disease is lung adenocarcinoma.